Jemoya, El Jhea Yvonne G.

HRN: 17-01-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
MUPIROCIN 2%, 15G (TUBE)
06/03/2026
06/10/2026
TOPICAL
15g
BID
Skin Lesion / Infection
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: